Cargando…
Safety of Stereotactic Body Radiation Therapy for Seven Ipsilateral Lung Lesions
Our patient is a 48-year-old gentleman who initially was diagnosed with stage IV colorectal cancer on presentation. He had a history of multiple lines of systemic therapy, primary local resection, radioembolization treatments to the liver, along with liver metastasectomy with intraoperative radiofre...
Autores principales: | Bernard, Mark E, Critchfield, Lana, Kudrimoti, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377660/ https://www.ncbi.nlm.nih.gov/pubmed/32714697 http://dx.doi.org/10.7759/cureus.8759 |
Ejemplares similares
-
Feasibility of using ring‐mounted Halcyon Linac for single‐isocenter/two‐lesion lung stereotactic body radiation therapy
por: Pokhrel, Damodar, et al.
Publicado: (2022) -
Risk of target coverage loss for stereotactic body radiotherapy treatment of synchronous lung lesions via single‐isocenter volumetric modulated arc therapy
por: Critchfield, Lana C., et al.
Publicado: (2020) -
Automation and integration of a novel restricted single‐isocenter stereotactic body radiotherapy (a‐RESIST) method for synchronous two lung lesions
por: Critchfield, Lana Sanford, et al.
Publicado: (2021) -
Clinical validation of ring‐mounted halcyon linac for lung SBRT: comparison to SBRT‐dedicated C‐arm linac treatments
por: Pokhrel, Damodar, et al.
Publicado: (2020) -
Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
por: Moiseenko, Vitali, et al.
Publicado: (2020)